Molbio Diagnostics Schedules Board Meeting for Q2 FY27 Financial Results
Molbio Diagnostics Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
Molbio Diagnostics Schedules Board Meeting for Q2 FY27 Financial Results Molbio Diagnostics Limited has scheduled a Board of Directors meeting on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed from 1st Oct'26 until 48 hours after the declaration of the financial results.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 路 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company 路 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. 路 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 路 06 Nov 2026
- Investor presentation 路 05 Nov 2026
- Outcome of the Board Meeting 路 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. 路 05 Nov 2026
